The Reactivities of HIV-1+Human Sera with Solid-Phase V3 Loop Peptides Can Be Poor Predictors of Their Reactivities with V3 Loops on Native gp120 Molecules
- 1 March 1993
- journal article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 9 (3) , 209-219
- https://doi.org/10.1089/aid.1993.9.209
Abstract
The binding of HIV-1+ human serum antibodies to solid phase-adsorbed V3 loop peptides from the IIIB, SF-2, and MN isolates was compared with the abilities of the same peptides to inhibit binding of the sera to the homologous or heterologous native gp120 molecules. The reactivities of the sera with the solid-phase peptides were found to be poor predictors of the potencies of the peptides as competitors in solution for antibody binding to the V3 loop in situ. Furthermore, the extent of cross-reaction of HIV-1+ human serum antibodies with the three V3 peptides in solid-phase assays was potently influenced by the presence or absence of nonionic detergent. Because the use of solid-phase V3 peptide assays is widespread, and there is no consensus on the use or omission of detergent, there is considerable potential for confusion. These factors should be considered when interpreting data derived from V3 peptide serology when this method is used to dissect the human immune response to HIV-1 infection. It is also shown in quantitative studies of HIV-1+ serum antibody binding to homologous and heterologous gp120s that the general anti-gp120 antibody response is significantly "type specific" for the homologous gp120.Keywords
This publication has 49 references indexed in Scilit:
- Characterization of the Specificity of the Human Antibody Response to the V3 Neutralization Domain of HIV-1AIDS Research and Human Retroviruses, 1992
- In Vitro Inhibition of a Variety of Human Immunodeficiency Virus Isolates by a Broadly Reactive, V3-Directed Heteroconjugate AntibodyThe Journal of Infectious Diseases, 1992
- Peptides Mimicking Selected Disulfide Loops in HIV-1 gp120, Other Than V3, Do Not Elicit Virus-Neutralizing AntibodiesAIDS Research and Human Retroviruses, 1991
- Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing DeterminantScience, 1990
- Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1)Molecular Immunology, 1990
- C-Terminal Fragments of gpl20 and Synthetic Peptides from Five HTLV-III Strains: Prevalence of Antibodies to the HTLV-III-MN Isolate in Infected IndividualsAIDS Research and Human Retroviruses, 1990
- Predominance of HIV-1 serotype distinct from LAV-1/HTLV-IIIBThe Lancet, 1990
- An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1AIDS, 1989
- Linear versus conformational variation of V3 neutralization domains of HIV-1 during experimental and natural infectionAIDS, 1989
- Theoretical analysis of the sensitivity of the solid phase antibody assay (ELISA)Molecular Immunology, 1987